The first miRNA acting on p27Kip1 to be identified have been miRNA221/222 whose activity downregulates p27Kip1 in several human malignancies, such as glioblastoma, prostate, triple negative breast cancers, hepatocellular, and papillary thyroid carcinoma. Here, CDKN1B is linked to triple-negative breast carcinoma.